Familial atypical hemolytic uremic syndrome: A review of its genetic and clinical aspects

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Bu, Fengxiao ^a,b   Borsa, Nicolo ^c   Gianluigi, Ardissino ^c   Smith, Richard J H ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H RECEPTOR; COMPLEMENT FACTOR I; COMPLEMENT RECEPTOR; ECULIZUMAB; FRESH FROZEN PLASMA; HAPTOGLOBIN; HEMOGLOBIN; LACTATE DEHYDROGENASE; MEMBRANE COFACTOR PROTEIN; UNCLASSIFIED DRUG; COMPLEMENT;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; COOMBS TEST; GENE MUTATION; GENETIC RISK; HAPLOTYPE; HEMOGLOBIN BLOOD LEVEL; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN EXPERIMENT; INNATE IMMUNITY; LACTATE DEHYDROGENASE BLOOD LEVEL; MISSENSE MUTATION; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC VARIABILITY; GENETICS; IMMUNOLOGY;

COMPLEMENT SYSTEM PROTEINS; GENETIC VARIATION; HEMOLYTIC-UREMIC SYNDROME; HUMANS;

EID: 84870161177     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/370426     Document Type: Review

References (60)

1. Noris M., Remuzzi G., Atypical hemolytic-uremic syndrome. The New England Journal of Medicine 2009 361 17 1675 1687 2-s2.0-70350279315
2. Constantinescu A. R., Bitzan M., Weiss L. S., Christen E., Kaplan B. S., Cnaan A., Trachtman H., Non-enteropathic hemolytic uremic syndrome: causes and short-term course. American Journal of Kidney Diseases 2004 43 6 976 982 2-s2.0-2542420109 (Pubitemid 38691492)
3. Noris M., Caprioli J., Bresin E., Mossali C., Pianetti G., Gamba S., Daina E., Fenili C., Castelletti F., Sorosina A., Piras R., Donadelli R., Maranta R., Van Der Meer I., Conway E. M., Zipfel P. F., Goodship T. H., Remuzzi G., Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clinical Journal of the American Society of Nephrology 2010 5 10 1844 1859 2-s2.0-77958587405 10.2215/CJN.02210310
4. Sellier-Leclerc A. L., Frémeaux-Bacchi V., Dragon-Durey M. A., Macher M. A., Niaudet P., Guest G., Boudailliez B., Bouissou F., Deschenes G., Gie S., Tsimaratos M., Fischbach M., Morin D., Nivet H., Alberti C., Loirat C., Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome. Journal of the American Society of Nephrology 2007 18 8 2392 2400 2-s2.0-34547633064 10.1681/ASN.2006080811 (Pubitemid 47203855)
5. Noris M., Remuzzi G., Pagon R. A., Bird T. D., Dolan C. R., Atypical hemolytic-uremic syndrome. GeneReviews 1993 Seattle, Wash, USA
6. Dragon-Durey M. A., Sethi S. K., Bagga A., Blanc C., Blouin J., Ranchin B., André J. L., Takagi N., Cheong H. I., Hari P., Le Quintrec M., Niaudet P., Loirat C., Fridman W. H., Frémeaux-Bacchi V., Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome. Journal of the American Society of Nephrology 2010 21 12 2180 2187 2-s2.0-78649863686 10.1681/ASN.2010030315
7. Caprioli J., Noris M., Brioschi S., Pianetti G., Castelletti F., Bettinaglio P., Mele C., Bresin E., Cassis L., Gamba S., Porrati F., Bucchioni S., Monteferrante G., Fang C. J., Liszewski M. K., Kavanagh D., Atkinson J. P., Remuzzi G., Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood 2006 108 4 1267 1279 2-s2.0-33747159590 10.1182/blood-2005-10-007252 (Pubitemid 44232024)
8. de Córdoba S. R., AHUS: a disorder with many risk factors. Blood 2010 115 2 158 160 2-s2.0-77950428338 10.1182/blood-2009-11-252627
9. Brown J. H., Tellez J., Wilson V., Postpartum aHUS secondary to a genetic abnormality in factor H acquired through liver transplantation. American Journal of Transplantation 2012 12 6 1632 1636
10. Zipfel P. F., Skerka C., Complement regulators and inhibitory proteins. Nature Reviews Immunology 2009 9 10 729 740 2-s2.0-70349437186 10.1038/nri2620
11. Dodds A. W., Which came first, the lectin/classical pathway or the alternative pathway of complement? Immunobiology 2002 205 4-5 340 354 2-s2.0-0036748150 (Pubitemid 35153952)
12. Porter R. R., Reid K. B. M., Activation of the complement system by antibody-antigen complexes: the classical pathway. Advances in Protein Chemistry 1979 33 1 71 2-s2.0-0018590717 10.1016/S0065-3233(08)60458-1
13. Turner M. W., The lectin pathway of complement activation. Research in Immunology 1996 147 2 110 115 2-s2.0-0029938895 10.1016/0923-2494(96)87184-7 (Pubitemid 26180574)
14. Matsushita M., The lectin pathway of the complement system. Microbiology and Immunology 1996 40 12 887 893 2-s2.0-0030443077 (Pubitemid 27014313)
15. Holers V. M., The spectrum of complement alternative pathway-mediated diseases. Immunological Reviews 2008 223 1 300 316 2-s2.0-47249120139 10.1111/j.1600-065X.2008.00641.x (Pubitemid 351986186)
16. Pangburn M. K., Muller-Eberhard H. J., The alternative pathway of complement. Springer Seminars in Immunopathology 1984 7 2-3 163 192 2-s2.0-0021146002 (Pubitemid 14010635)
17. Liszewski M. K., Fang C. J., Atkinson J. P., Inhibiting complement activation on cells at the step of C3 cleavage. Vaccine 2008 26, supplement 8 I22 I27 2-s2.0-57649143877 10.1016/j.vaccine.2008.11.001
18. Janssen B. J. C., Gros P., Conformational complexity of complement component C3. Advances in Experimental Medicine and Biology 2006 586 291 312 2-s2.0-33751036565 10.1007/0-387-34134-X-20
19. Perkins S. J., Nan R., Okemefuna A. I., Li K., Khan S., Miller A., Multiple interactions of complement factor h with its ligands in solution: a progress report. Advances in Experimental Medicine and Biology 2010 703 25 47 2-s2.0-77955965634 10.1007/978-1-4419-5635-43
20. Skerka C., Zipfel P. F., Complement factor H related proteins in immune diseases. Vaccine 2008 26, supplement 8 I9 I14 2-s2.0-57649230771 10.1016/j.vaccine.2008.11.021
21. Pangburn M. K., Rawal N., Structure and function of complement C5 convertase enzymes. Biochemical Society Transactions 2002 30 6 1006 1010 2-s2.0-0036865356 10.1042/BST0301006 (Pubitemid 36002396)
22. Morgan B. P., Regulation of the complement membrane attack pathway. Critical Reviews in Immunology 1999 19 3 173 198 2-s2.0-0033064619 (Pubitemid 29321438)
23. Muller-Eberhard H. J., The membrane attack complex of complement. Annual Review of Immunology 1986 4 503 528
24. Petruzziello-Pellegrini T. N., Marsden P. A., Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics. Current Opinion in Nephrology and Hypertension 2012 21 4 433 440
25. Poolpol K., Gadner B., Neururer S., Mellmann A., Karch H., Orth D., Würzner R., Do complement factor H 402Y and C7 M allotypes predispose to (typical) haemolytic uraemic syndrome? International Journal of Immunogenetics 2011 38 5 383 387 2-s2.0-79957957687 10.1111/j.1744-313X.2011.01017.x
26. Campbell S., Carré I. J., Fatal haemolytic uraemic syndrome and idiopathic hyperlipaemia in monozygotic twins. Archives of Disease in Childhood 1965 40 214 654 658 2-s2.0-0013833869
27. Boon C. J. F., van de Kar N. C., Klevering B. J., Keunen J. E. E., Cremers F. P. M., Klaver C. C. W., Hoyng C. B., Daha M. R., den Hollander A. I., The spectrum of phenotypes caused by variants in the CFH gene. Molecular Immunology 2009 46 8-9 1573 1594 2-s2.0-64149117800 10.1016/j.molimm.2009.02.013
28. Warwicker P., Goodship T. H. J., Donne R. L., Pirson Y., Nicholls A., Ward R. M., Turnpenny P., Goodship J. A., Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney International 1998 53 4 836 844 2-s2.0-0031970553 10.1111/j.1523-1755.1998.00824.x (Pubitemid 28155655)
29. Martinez-Barricarte R., Pianetti G., Gautard R., Misselwitz J., Strain L., Frémeaux-Bacchi V., Skerka C., Zipfel P. F., Goodship T., Noris M., Remuzzi G., De Cordoba S. R., The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome. Journal of the American Society of Nephrology 2008 19 3 639 646 2-s2.0-40449085427 10.1681/ASN. 2007080923 (Pubitemid 351355408)
30. Caprioli J., Castelletti F., Bucchioni S., Bettinaglio P., Bresin E., Pianetti G., Gamba S., Brioschi S., Daina E., Remuzzi G., Noris M., Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Human Molecular Genetics 2003 12 24 3385 3395 2-s2.0-0242601270 10.1093/hmg/ddg363 (Pubitemid 37541083)
31. Ying L., Katz Y., Schlesinger M., Carmi R., Shalev H., Haider N., Beck G., Sheffield V. C., Landau D., Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. American Journal of Human Genetics 1999 65 6 1538 1546 2-s2.0-0033362094 10.1086/302673 (Pubitemid 30468666)
32. Hakobyan S., Tortajada A., Harris C. L., De Córdoba S. R., Morgan B. P., Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome. Kidney International 2010 78 8 782 788 2-s2.0-77957575143 10.1038/ki.2010.275
33. Sullivan M., Erlic Z., Hoffmann M. M., Arbeiter K., Patzer L., Budde K., Hoppe B., Zeier M., Lhotta K., Rybicki L. A., Bock A., Berisha G., Neumann H. P. H., Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome. Annals of Human Genetics 2010 74 1 17 26 2-s2.0-72549097037 10.1111/j.1469-1809.2009.00554.x
34. Habibi I., Sfar I., Ben Alaya W., Atypical hemolytic uremic syndrome and mutation analysis of factor H gene in two Tunisian families. International Journal of Nephrology and Renovascular Disease 2010 3 85 92
35. Roumenina L. T., Loirat C., Dragon-Durey M. A., Halbwachs-Mecarelli L., Sautes-Fridman C., Frémeaux-Bacchi V., Alternative complement pathway assessment in patients with atypical HUS. Journal of Immunological Methods 2011 365 1-2 8 26 2-s2.0-79551595553 10.1016/j.jim.2010.12.020
36. Sofat R., Casas J. P., Webster A. R., Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype. International Journal of Epidemiology 2012 41 1 250 262
37. Servais A., Noël L. H., Roumenina L. T., Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney International 2012 82 4 454 464
38. Francis N. J., McNicholas B., Awan A., A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome. Blood 2012 119 2 591 601
39. Cardone J., Le Friec G., Kemper C., CD46 in innate and adaptive immunity: an update. Clinical and Experimental Immunology 2011 164 3 301 311 2-s2.0-79955477674 10.1111/j.1365-2249.2011.04400.x
40. Richards A., Kemp E. J., Liszewski M. K., Goodship J. A., Lampe A. K., Decorte R., Müslümanolu M. H., Kavukcu S., Filler G., Pirson Y., Wen L. S., Atkinson J. P., Goodship T. H. J., Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proceedings of the National Academy of Sciences of the United States of America 2003 100 22 12966 12971 2-s2.0-0242331610 10.1073/pnas.2135497100 (Pubitemid 37340009)
41. Noris M., Brioschi S., Caprioli J., Todeschini M., Bresin E., Porrati F., Gamba S., Remuzzi G., Familial haemolytic uraemic syndrome and an MCP mutation. The Lancet 2003 362 9395 1542 1547 2-s2.0-0242570482 10.1016/S0140-6736(03) 14742-3 (Pubitemid 37410193)
42. Frémeaux-Bacchi V., Moulton E. A., Kavanagh D., Dragon-Durey M. A., Blouin J., Caudy A., Arzouk N., Cleper R., Francois M., Guest G., Pourrat J., Seligman R., Fridman W. H., Loirat C., Atkinson J. P., Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome. Journal of the American Society of Nephrology 2006 17 7 2017 2025 2-s2.0-33745812440 10.1681/ASN.2005101051 (Pubitemid 44036186)
43. Esparza-Gordillo J., Jorge E. G. D., Garrido C. A., Carreras L., López-Trascasa M., Sánchez-Corral P., De Córdoba S. R., Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree. Molecular Immunology 2006 43 11 1769 1775 2-s2.0-33644964155 10.1016/j.molimm.2005.11.008
44. Provaznikova D., Rittich S., Malina M., Seeman T., Marinov I., Riedl M., Hrachovinova I., Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP. Pediatric Nephrology 2012 27 1 73 81 2-s2.0-79959435717 10.1007/s00467-011-1943-5
45. Liszewski M. K., Kemper C., Price J. D., Atkinson J. P., Emerging roles and new functions of CD46. Springer Seminars in Immunopathology 2005 27 3 345 358 2-s2.0-27844526064 10.1007/s00281-005-0002-3 (Pubitemid 41639886)
46. Richards A., Kathryn Liszewski M., Kavanagh D., Fang C. J., Moulton E., Frémeaux-Bacchi V., Remuzzi G., Noris M., Goodship T. H. J., Atkinson J. P., Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome. Molecular Immunology 2007 44 1-3 111 122 2-s2.0-33751035523 10.1016/j.molimm.2006.07.004 (Pubitemid 44754841)
47. Saunders R. E., Abarrategui-Garrido C., Frémeaux-Bacchi V., Goicoechea De Jorge E., Goodship T. H. J., López Trascasa M., Noris M., Ponce Castro I. M., Remuzzi G., Rodríguez De Córdoba S., Sánchez-Corral P., Skerka C., Zipfel P. F., Perkins S. J., The interactive factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and factor I mutations with structural models. Human Mutation 2007 28 3 222 234 2-s2.0-33847237272 10.1002/humu.20435
48. Esparza-Gordillo J., Goicoechea de Jorge E., Buil A., Berges L. C., López-Trascasa M., Sánchez-Corral P., Rodríguez de Córdoba S., Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. Human Molecular Genetics 2005 14 5 703 712 2-s2.0-14644424005 10.1093/hmg/ddi066 (Pubitemid 40309595)
49. Ermini L., Goodship T. H., Strain L., Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS. Molecular Immunology 2012 49 4 640 648
50. Frémeaux-Bacchi V., Miller E. C., Liszewski M. K., Strain L., Blouin J., Brown A. L., Moghal N., Kaplan B. S., Weiss R. A., Lhotta K., Kapur G., Mattoo T., Nivet H., Wong W., Gie S., De Ligny B. H., Fischbach M., Gupta R., Hauhart R., Meunier V., Loirat C., Dragon-Durey M. A., Fridman W. H., Janssen B. J. C., Goodship T. H. J., Atkinson J. P., Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 2008 112 13 4948 4952 2-s2.0-54049137505 10.1182/blood-2008-01-133702
51. Lhotta D. K., Janecke A. R., Scheiring J., Petzlberger B., Giner T., Fally V., Würzner R., Zimmerhackl L. B., Mayer G., Frémeaux-Bacchi V., A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure. Clinical Journal of the American Society of Nephrology 2009 4 8 1356 1362 2-s2.0-70349923265 10.2215/CJN.06281208
52. Sartz L., Olin A. I., Kristoffersson A. C., A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome. Journal of Immunology 2012 188 4 2030 2037
53. Goicoechea de Jorge E., Harris C. L., Esparza-Gordillo J., Carreras L., Aller Arranz E., Abarrategui Garrido C., López-Trascasa M., Sánchez-Corral P., Morgan B. P., Rodríguez De Córdoba S., Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proceedings of the National Academy of Sciences of the United States of America 2007 104 1 240 245 2-s2.0-33846094404 10.1073/pnas.0603420103 (Pubitemid 46068016)
54. Alper C. A., Rosen F. S., Lachmann P. J., Inactivator of the third component of complement as an inhibitor in the properdin pathway. Proceedings of the National Academy of Sciences of the United States of America 1972 69 10 2910 2913 2-s2.0-0015407492
55. Nilsson S. C., Sim R. B., Lea S. M., Complement factor I in health and disease. Molecular Immunology 2011 48 14 1611 1620
56. Sullivan M., Rybicki L. A., Winter A., Age-related penetrance of hereditary atypical hemolytic uremic syndrome. Annals of Human Genetics 2011 75 6 639 647
57. Westra D., Wetzels J. F., Volokhina E. B., A new era in the diagnosis and treatment of atypical haemolytic uraemic syndrome. The Netherlands Journal of Medicine 2012 70 3 121 129
58. Loirat C., Frémeaux-Bacchi V., Atypical hemolytic uremic syndrome. Orphanet Journal of Rare Diseases 2011 6 60
59. Zuber J., Le Quintrec M., Sberro-Soussan R., Loirat C., Frémeaux-Bacchi V., Legendre C., New insights into postrenal transplant hemolytic uremic syndrome. Nature Reviews Nephrology 2011 7 1 23 35 2-s2.0-78650517945 10.1038/nrneph.2010.155
60. Saland J. M., Ruggenenti P., Remuzzi G., Consensus Study Group, Liver-kidney transplantation to cure atypical hemolytic uremic syndrome. Journal of the American Society of Nephrology 2009 20 5 940 949